Gentury

Gentury is US-based; biology focused preclinical drug discovery contract research organization. The company offers comprehensive technology platforms and expertise around Hit to Lead and Lead Optimization in preclinical drug discovery and development, which includes biology assays/assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company currently collaborates with 7 out of top 10 world pharmaceutical companies and many mid-sized pharmaceutical and biotech companies.

  • Assay Development

    GPCRs, kinases, Ion channels and transporters etc. with HTS technology

  • High Throughput Screening

    In both 96-well and 384-well formats and capable of producing 50,000 datapoints per day

  • Compound Profiling

    GPCRs & Kinase selectivity panel profiling, Genetic Biomarker profiling in mRNA, DNA methylatio

  • Integrated Biological Services

    We provide a full package of services from Hit ID to preclinical development.

  • In Vivo Pharmacology & Disease Models

    CNS Disorders, Oncology,Metabiolic Diseases, Inflammation

  • Custom Antibody Services

    Experience A Guaranteed, Customized, One Stop Service

  • DMPK & Bioanalytics

    PK/PD, ADME, Solubility, Stability, Caco-2 etc.

  • Natural Products & Lead Identification

    We provide herbal extracts together with therapeutic focused libraries

  • Safety & Toxicology

    We provide Safety and Toxicology service both in vitro and in vivo models

  • Reagent Provision

    Protein Interaction Our protein and antibody arrays analyze human proteomes of cancer and other pathologies